Jefferies raised the firm’s price target on Nutrien (NTR) to $63 from $62 and keeps a Buy rating on the shares. Q1 EPS of 11c was 42c below consensus and 21c below the firm’s estimate, though the 2025 full-year outlook remains intact, supported by $200M in cost-saving initiatives, the analyst tells investors. Macro uncertainties continue to linger, but Nutrien continues to focus on U.S. retail tuck-in acquisitions and divestiture opportunities for non-core assets, the analyst added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTR:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue